Literature DB >> 30236814

Proton Magnetic Resonance Spectroscopy (H1-MRS) Study of the Ketogenic Diet on Repetitive Mild Traumatic Brain Injury in Adolescent Rats and Its Effect on Neurodegeneration.

Fengchen Zhang1, Hui Wu1, Yichao Jin2, Xiaohua Zhang3.   

Abstract

OBJECTIVE: A ketogenic diet (KD) improves cellular metabolism and functional recovery after moderate-to-severe traumatic brain injury. Here, we evaluated the changes of neurochemical metabolites after KD therapy for repetitive mild traumatic brain injury (rmTBI) and its possible role in neurodegeneration.
METHODS: Postnatal day 35 rats were randomly divided into 3 groups: sham, control, and KD groups. Rats in control and KD groups were given 3 rmTBI by a fluid percussion traumatic brain injury device 24 hours apart. All rats were killed at 7 days after the last injury. The ipsilateral cortex were analyzed with hematoxylin and eosin staining; beta-hydroxybutyrate was measured; conventional magnetic resonance imaging and the dry-wet weight method were used to assess the brain edema; changes of neurochemical metabolites were assessed using the ratio of N-acetylaspartate (NAA)/creatine (Cr), choline compound (Cho)/Cr, and NAA/Cho with magnetic resonance spectroscopy; the effect of KD therapy on neurodegeneration was evaluated with double immunofluorescence staining of Iba-1/beclin-1; behavioral outcome was assessed with beam walk/beam balance tests.
RESULTS: KD significantly elevated beta-hydroxybutyrate levels, and there was no brain edema associated with rmTBI and KD therapy; behavioral assessment showed KD therapy significantly improved motor performance; magnetic resonance spectroscopy showed that rmTBI reduced the ratio of NAA/Cr and had no effect on the ratios of Cho/Cr and NAA/Cho whereas KD increased the ratio of NAA/Cr; double immunofluorescence staining showed KD therapy could significantly decrease microglial beclin-1 expression in the ipsilateral cortex.
CONCLUSIONS: These results suggest the effect of KD on metabolic status and its possible role in preventing neurodegeneration in adolescent rats after rmTBI.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ketogenic diet; Magnetic resonance spectroscopy; Mild traumatic brain injury; Neurodegeneration

Mesh:

Year:  2018        PMID: 30236814     DOI: 10.1016/j.wneu.2018.09.037

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

Review 1.  Ketogenic regimens for acute neurotraumatic events.

Authors:  Ceren Yarar-Fisher; Jia Li; Erika D Womack; Amal Alharbi; Oscar Seira; Kathleen L Kolehmainen; Ward T Plunet; Nima Alaeiilkhchi; Wolfram Tetzlaff
Journal:  Curr Opin Biotechnol       Date:  2021-01-11       Impact factor: 10.279

2.  MRI spectroscopic and tractography studies indicate consequences of long-term ketogenic diet.

Authors:  Kinga Gzieło; Krzysztof Janeczko; Władysław Węglarz; Krzysztof Jasiński; Krzysztof Kłodowski; Zuzanna Setkowicz
Journal:  Brain Struct Funct       Date:  2020-07-17       Impact factor: 3.270

Review 3.  Ketone Supplementation: Meeting the Needs of the Brain in an Energy Crisis.

Authors:  Angela M Poff; Sara Moss; Maricel Soliven; Dominic P D'Agostino
Journal:  Front Nutr       Date:  2021-12-23

Review 4.  Pathophysiology of Pediatric Traumatic Brain Injury.

Authors:  Rebecka O Serpa; Lindsay Ferguson; Cooper Larson; Julie Bailard; Samantha Cooke; Tiffany Greco; Mayumi L Prins
Journal:  Front Neurol       Date:  2021-07-15       Impact factor: 4.003

5.  Ketogenic Diet as a potential treatment for traumatic brain injury in mice.

Authors:  Meirav Har-Even; Vardit Rubovitch; Whitney A Ratliff; Bar Richmond-Hacham; Bruce A Citron; Chaim G Pick
Journal:  Sci Rep       Date:  2021-12-07       Impact factor: 4.379

6.  Ketogenic diet reduces early mortality following traumatic brain injury in Drosophila via the PPARγ ortholog Eip75B.

Authors:  Joseph Blommer; Megan C Fischer; Athena R Olszewski; Rebeccah J Katzenberger; Barry Ganetzky; David A Wassarman
Journal:  PLoS One       Date:  2021-10-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.